Your browser doesn't support javascript.
loading
Comparison of 3-month cytogenetic and molecular assays for early assessment of long-term clinical impact after BCR-ABL1 tyrosine kinase inhibitor treatment in chronic myeloid leukemia.
Kee, Kyung-Mi; Kim, Soo-Hyun; Yang, Seon-Young; Shin, Jeong-U; Nam, Yoon-Won; Jang, Eun-Jung; Kim, Hong-Tae; Lee, Se-Min; Park, Sung-Ho; Kim, Dong-Wook.
Affiliation
  • Kee KM; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Kim SH; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Yang SY; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Shin JU; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Nam YW; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Jang EJ; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea.
  • Kim HT; Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, South Korea; Center for Genomic Integrity, Institute for Basic Science (IBS), UNIST, Ulsan, South Korea.
  • Lee SM; Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, South Korea.
  • Park SH; Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, South Korea.
  • Kim DW; Leukemia Research Institute, The Catholic University of Korea, Seoul, South Korea; Catholic Hematology Hospital, The Catholic University of Korea, Seoul, South Korea. Electronic address: dwkim@eulji.ac.kr.
Leuk Res ; 112: 106754, 2022 01.
Article in En | MEDLINE | ID: mdl-34906861
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Fusion Proteins, bcr-abl / Cytogenetic Analysis / Imatinib Mesylate Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2022 Document type: Article Affiliation country: South Korea
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Fusion Proteins, bcr-abl / Cytogenetic Analysis / Imatinib Mesylate Type of study: Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2022 Document type: Article Affiliation country: South Korea